The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.

 
Web www.patentalert.com

< Chicken growth hormone releasing hormone receptor

< Body fluid flow control method and device

> Methods and apparatus for remodeling an extravascular tissue structure

> Lipoprotein-regulating medicaments
~ 00276